Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 44% ± 22% | |
neuron | 4 studies | 23% ± 8% | |
amacrine cell | 4 studies | 26% ± 4% | |
pancreatic A cell | 3 studies | 46% ± 21% | |
type B pancreatic cell | 3 studies | 58% ± 20% | |
retinal ganglion cell | 3 studies | 36% ± 13% | |
GABAergic neuron | 3 studies | 36% ± 12% | |
enteroendocrine cell | 3 studies | 28% ± 10% | |
goblet cell | 3 studies | 44% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 91% | 10143.96 | 224 / 245 | 100% | 157.54 | 502 / 502 |
breast | 75% | 1940.87 | 346 / 459 | 96% | 58.44 | 1072 / 1118 |
liver | 100% | 10738.20 | 225 / 226 | 60% | 29.84 | 245 / 406 |
brain | 90% | 7605.81 | 2369 / 2642 | 52% | 17.93 | 369 / 705 |
pancreas | 79% | 1456.52 | 259 / 328 | 57% | 22.32 | 101 / 178 |
intestine | 39% | 621.42 | 372 / 966 | 74% | 28.60 | 392 / 527 |
thymus | 76% | 1869.77 | 495 / 653 | 26% | 3.97 | 156 / 605 |
heart | 90% | 2197.82 | 773 / 861 | 0% | 0 | 0 / 0 |
uterus | 39% | 401.09 | 66 / 170 | 49% | 11.15 | 226 / 459 |
bladder | 19% | 160.00 | 4 / 21 | 59% | 16.94 | 297 / 504 |
lung | 16% | 181.74 | 92 / 578 | 57% | 19.73 | 659 / 1155 |
adrenal gland | 9% | 162.45 | 23 / 258 | 60% | 33.24 | 138 / 230 |
stomach | 9% | 89.67 | 31 / 359 | 56% | 23.57 | 159 / 286 |
esophagus | 14% | 164.22 | 206 / 1445 | 48% | 13.23 | 87 / 183 |
kidney | 43% | 874.35 | 38 / 89 | 9% | 3.25 | 80 / 901 |
skin | 36% | 473.78 | 653 / 1809 | 4% | 0.83 | 20 / 472 |
adipose | 38% | 417.43 | 460 / 1204 | 0% | 0 | 0 / 0 |
ovary | 4% | 39.64 | 8 / 180 | 30% | 4.85 | 128 / 430 |
tonsil | 0% | 0 | 0 / 0 | 24% | 5.27 | 11 / 45 |
spleen | 8% | 89.24 | 19 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.72 | 4 / 80 |
blood vessel | 1% | 9.56 | 12 / 1335 | 0% | 0 | 0 / 0 |
muscle | 1% | 5.72 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0036465 | Biological process | synaptic vesicle recycling |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_0048791 | Biological process | calcium ion-regulated exocytosis of neurotransmitter |
GO_1900242 | Biological process | regulation of synaptic vesicle endocytosis |
GO_0046850 | Biological process | regulation of bone remodeling |
GO_1990926 | Biological process | short-term synaptic potentiation |
GO_0090385 | Biological process | phagosome-lysosome fusion |
GO_0045956 | Biological process | positive regulation of calcium ion-dependent exocytosis |
GO_0006909 | Biological process | phagocytosis |
GO_0050764 | Biological process | regulation of phagocytosis |
GO_0070092 | Biological process | regulation of glucagon secretion |
GO_0090119 | Biological process | vesicle-mediated cholesterol transport |
GO_1990927 | Biological process | calcium ion regulated lysosome exocytosis |
GO_0006906 | Biological process | vesicle fusion |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0032009 | Cellular component | early phagosome |
GO_0005764 | Cellular component | lysosome |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005777 | Cellular component | peroxisome |
GO_0098686 | Cellular component | hippocampal mossy fiber to CA3 synapse |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0005829 | Cellular component | cytosol |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0045202 | Cellular component | synapse |
GO_0031045 | Cellular component | dense core granule |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0030424 | Cellular component | axon |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0000149 | Molecular function | SNARE binding |
GO_0030276 | Molecular function | clathrin binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0019905 | Molecular function | syntaxin binding |
Gene name | SYT7 |
Protein name | Alternative protein SYT7 (cDNA FLJ53554) Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) Synaptotagmin 7 |
Synonyms | PCANAP7 |
Description | FUNCTION: Ca(2+) sensor involved in Ca(2+)-dependent exocytosis of secretory and synaptic vesicles through Ca(2+) and phospholipid binding to the C2 domain (By similarity). Ca(2+) induces binding of the C2-domains to phospholipid membranes and to assembled SNARE-complexes; both actions contribute to triggering exocytosis (By similarity). SYT7 binds Ca(2+) with high affinity and slow kinetics compared to other synaptotagmins (By similarity). Involved in Ca(2+)-triggered lysosomal exocytosis, a major component of the plasma membrane repair . Ca(2+)-regulated delivery of lysosomal membranes to the cell surface is also involved in the phagocytic uptake of particles by macrophages (By similarity). Ca(2+)-triggered lysosomal exocytosis also plays a role in bone remodeling by regulating secretory pathways in osteoclasts and osteoblasts (By similarity). In case of infection, involved in participates cell invasion by Trypanosoma cruzi via Ca(2+)-triggered lysosomal exocytosis . Involved in cholesterol transport from lysosome to peroxisome by promoting membrane contacts between lysosomes and peroxisomes: probably acts by promoting vesicle fusion by binding phosphatidylinositol-4,5-bisphosphate on peroxisomal membranes (By similarity). Acts as a key mediator of synaptic facilitation, a process also named short-term synaptic potentiation: synaptic facilitation takes place at synapses with a low initial release probability and is caused by influx of Ca(2+) into the axon terminal after spike generation, increasing the release probability of neurotransmitters (By similarity). Probably mediates synaptic facilitation by directly increasing the probability of release (By similarity). May also contribute to synaptic facilitation by regulating synaptic vesicle replenishment, a process required to ensure that synaptic vesicles are ready for the arrival of the next action potential: SYT7 is required for synaptic vesicle replenishment by acting as a sensor for Ca(2+) and by forming a complex with calmodulin (By similarity). Also acts as a regulator of Ca(2+)-dependent insulin and glucagon secretion in beta-cells (By similarity). Triggers exocytosis by promoting fusion pore opening and fusion pore expansion in chromaffin cells (By similarity). Also regulates the secretion of some non-synaptic secretory granules of specialized cells (By similarity). . |
Accessions | F5GX00 ENST00000542836.5 [O43581-6] O43581 ENST00000540677.5 [O43581-2] ENST00000539468.5 F5H8G7 ENST00000545053.1 ENST00000535826.5 [O43581-5] B4DGK4 ENST00000263846.8 [O43581-1] ENST00000539246.5 ENST00000539008.6 [O43581-3] ENST00000542670.5 [O43581-4] |